Forskning 2008 - Herlev Hospital

herlevhospital.dk

Forskning 2008 - Herlev Hospital

Forskning 2008

low voltage pulse combinations for gene electrotransfer

in muscle. Hum Gene Ther 2008;19:1249-60.

Kristensen B, Ejlertsen B, Mouridsen HT, Jensen MB,

Andersen J, Bjerregaard B, et al. Bisphosphonate

treatment in primary breast cancer: results from a

randomised comparison of oral pamidronate versus no

pamidronate in patients with primary breast cancer.

Acta oncologica (Stockholm, Sweden) 2008;47(4):740-6.

Kristensen BH, Laursen FJ, Logager V, Geertsen PF,

Krarup-Hansen A. Dosimetric and geometric evaluation

of an open low-field magnetic resonance simulator for

radiotherapy treatment planning of brain tumours.

Radiother Oncol 2008;87(1):100-9.

Kumler T, Gislason GH, Kirk V, Bay M, Nielsen OW,

Kober L, et al. Accuracy of a heart failure diagnosis in

administrative registers. European journal of heart failure

: journal of the Working Group on Heart Failure of

the European Society of Cardiology 2008;10(7):658-60.

Kvistborg P, Hadrup SR, Svane IM, Andersen MH,

Straten PT. Characterization of a single peptide derived

from cytochrome P450 1B1 that elicits spontaneous

human leukocyte antigen (HLA)-A1 as well as HLA-B35

restricted CD8 T-cell responses in cancer patients. Hum

Immunol 2008;69(4-5):266-72.

Madsen AR, Gundgaard MG, Hoff CM, Maaremd C,

Holmboe P, Knap M, et al. Cancer of the external

auditory canal and middle ear in Denmark from 1992

to 2001. Head and Neck-Journal for the Sciences and

Specialties of the Head and Neck 2008;30(10):1332-8.

Marklund M, Torp-Pedersen S, Bentzon N, Thomsen

C, Roslind A, Nolsoe CR. Contrast kinetics of

the malignant breast tumour - Border versus centre

enhancement on dynamic midfield MRI. Eur J Radiol

2008;65(2):279-85.

Met O, Eriksen J, Svane IM. Studies on mRNA electroporation

of immature and mature dendritic cells:

Effects on their immunogenic potential. Mol Biotechnol

2008;40(2):151-60.

Nielsen AR, Hojman P, Erikstrup C, Fischer CP, Plomgaard

P, Mounier R, et al. Association between interleukin-15

and obesity: interleukin-15 as a potential regulator

of fat mass. The Journal of clinical endocrinology

and metabolism 2008;93(11):4486-93.

Nielsen KV, Ejlertsen B, Moller S, Jorgensen JT, Knoop

A, Knudsen H, et al. The value of TOP2A gene copy

number variation as a biomarker in breast cancer:

Update of DBCG trial 89D. Acta oncologica (Stockholm,

Sweden) 2008;47(4):725-34.

O’Neill L, Armstrong J, Buckney S, Assiri M, Cannon

M, Holmberg O. A phase II trial for the optimisation of

treatment position in the radiation therapy of prostate

cancer. Radiother Oncol 2008;88(1):61-6.

Ottosson RO, Engstrom PE, Sjostrom D, Behrens CF,

Karlsson A, Knoos T, et al. The feasibility of using Pareto

fronts for comparison of treatment planning systems

and delivery techniques. Acta oncologica (Stockholm,

Sweden) 2008;1-5.

Persson GF, Nygaard DE, Olsen M, Juhler-Nottrup T,

Pedersen AN, Specht L, et al. Can audio coached 4D CT

emulate free breathing during the treatment course?

Acta Oncol 2008;47(7):1397-405.

Pfeiffer P, Nielsen D, Bjerregaard J, Qvortrup C, Yilmaz

M, Jensen B. Biweekly cetuximab and irinotecan as

third-line therapy in patients with advanced colorectal

cancer after failure to irinotecan, oxaliplatin and 5-

fluorouracil. Ann Oncol 2008;19(6):1141-5.

Roslind A, Johansen JS, Christensen LJ, Kiss K, Balslev

E, Nielsen DL, et al. High serum levels of YKL-40 in

patients with squamous cell carcinoma of the head and

neck are associated with short survival. Int J Cancer

2008;122(4):857-63.

Roslind A, Balslev E, Kruse H, Staergaard B, Horn

T. Subcellular localization of YKL-40 in normal and

malignant epithelial cells of the breast. Ultrastruct

Pathol 2008;32(3):101-6.

Roslind A, Knoop AS, Jensen MB, Johansen JS, Nielsen

DL, Price PA, et al. YKL-40 protein expression is not

a prognostic marker in patients with primary breast

cancer. Breast Cancer Res Treat 2008;112(2):275-85.

Ryberg M, Nielsen D, Cortese G, Nielsen G, Skovsgaard

T, Andersen PK. New Insight Into Epirubicin Cardiac

Toxicity: Competing Risks Analysis of 1097 Breast

Cancer Patients. JNCI Journal of the National Cancer

Institute 2008;100(15):158-67.

Scagliotti GV, Parikh P, von Pawel J, Biesma B,

Vansteenkiste J, Manegold C, et al. Phase III study

comparing cisplatin plus gemcitabine with cisplatin

plus pemetrexed in chemotherapy-naive patients with

advanced-stage non-small-cell lung cancer. J Clin Oncol

2008;26(21):3543-51.

Schonnemann KR, Jensen HA, Yilmaz M, Jensen BV,

Larsen O, Pfeiffer P. Phase II study of short-time oxaliplatin,

capecitabine and epirubicin (EXE) as first-line

therapy in patients with non-resectable gastric cancer.

Br J Cancer 2008;99(6):858-61.

35

More magazines by this user
Similar magazines